TrialJournal of hepato-biliary-pancreatic sciences2026

Neoadjuvant Chemotherapy With Gemcitabine/Cisplatin/S-1 for Resectable Biliary Tract Cancer With FDG-PET-Positive Lymph Node Metastasis (KHBO1201): A Multicenter Phase II Trial.

Satoshi Ogiso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.